250 related articles for article (PubMed ID: 18581955)
41. Combined opto-electronic perometry and bioimpedance to measure objectively the effectiveness of a new treatment intervention for chronic secondary leg lymphedema.
Moseley A; Piller N; Carati C
Lymphology; 2002 Dec; 35(4):136-43. PubMed ID: 12570322
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of secondary lymphedema in patients with head and neck cancer.
Deng J; Ridner SH; Dietrich MS; Wells N; Wallston KA; Sinard RJ; Cmelak AJ; Murphy BA
J Pain Symptom Manage; 2012 Feb; 43(2):244-52. PubMed ID: 21802897
[TBL] [Abstract][Full Text] [Related]
43. Post-breast cancer lymphedema: part 2.
Fu MR; Ridner SH; Armer J
Am J Nurs; 2009 Aug; 109(8):34-41; quiz 42. PubMed ID: 19641404
[TBL] [Abstract][Full Text] [Related]
44. Sensitivity and specificity of combined perimetric and volumetric evaluations in the diagnosis of arm lymphedema.
Godoy JM; Silva SH; Godoy MF
Prague Med Rep; 2007; 108(3):243-7. PubMed ID: 18399061
[TBL] [Abstract][Full Text] [Related]
45. Upper extremity lymphedema after treatment for breast cancer: a review of the literature.
Meneses KD; McNees MP
Ostomy Wound Manage; 2007 May; 53(5):16-29. PubMed ID: 17551172
[TBL] [Abstract][Full Text] [Related]
46. A simple and innovative device to measure arm volume at home for patients with lymphedema after breast cancer.
Lette J
J Clin Oncol; 2006 Dec; 24(34):5434-40. PubMed ID: 17135645
[TBL] [Abstract][Full Text] [Related]
47. Lymphedema: a comprehensive review.
Warren AG; Brorson H; Borud LJ; Slavin SA
Ann Plast Surg; 2007 Oct; 59(4):464-72. PubMed ID: 17901744
[TBL] [Abstract][Full Text] [Related]
48. Psychologic and social sequelae of secondary lymphedema: a review.
McWayne J; Heiney SP
Cancer; 2005 Aug; 104(3):457-66. PubMed ID: 15968692
[TBL] [Abstract][Full Text] [Related]
49. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema.
Ward LC; Czerniec S; Kilbreath SL
Breast Cancer Res Treat; 2009 Oct; 117(3):541-7. PubMed ID: 19082708
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer-related lymphoedema risk reduction advice: a challenge for health professionals.
Nielsen I; Gordon S; Selby A
Cancer Treat Rev; 2008 Nov; 34(7):621-8. PubMed ID: 18691823
[TBL] [Abstract][Full Text] [Related]
51. Lymphedema and the nurse practitioner.
Romero R
Nurse Pract Forum; 1999 Sep; 10(3):159-64. PubMed ID: 10614361
[TBL] [Abstract][Full Text] [Related]
52. Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function.
Hayes SC; Janda M; Cornish B; Battistutta D; Newman B
J Clin Oncol; 2008 Jul; 26(21):3536-42. PubMed ID: 18640935
[TBL] [Abstract][Full Text] [Related]
53. Research on risk assessment for secondary lymphedema following breast cancer treatment.
Armer JM
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2715-7. PubMed ID: 20978175
[No Abstract] [Full Text] [Related]
54. Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction.
Shah C; Arthur D; Riutta J; Whitworth P; Vicini FA
Breast J; 2012; 18(4):357-61. PubMed ID: 22759095
[TBL] [Abstract][Full Text] [Related]
55. Home volumetry foretells a new era of self-management for patients with lymphedema after breast cancer.
Lette J; Lette F; Fraser S
Lymphology; 2007 Dec; 40(4):185-7. PubMed ID: 18365533
[TBL] [Abstract][Full Text] [Related]
56. Segmental Impedance Thresholds for Early Detection of Unilateral Upper Limb Swelling.
Svensson BJ; Dylke ES; Ward LC; Kilbreath SL
Lymphat Res Biol; 2015 Dec; 13(4):253-9. PubMed ID: 24837521
[TBL] [Abstract][Full Text] [Related]
57. Segmental Bioimpedance Informs Diagnosis of Breast Cancer-Related Lymphedema.
Svensson BJ; Dylke ES; Ward LC; Kilbreath SL
Lymphat Res Biol; 2017 Dec; 15(4):349-355. PubMed ID: 28956701
[TBL] [Abstract][Full Text] [Related]
58. Circumference-Based Criteria for Detection of Secondary Arm Lymphedema for Chinese Women.
Wang H; Shen L; Liu T; Shao P; Dylke ES; Jia J; Kilbreath SL
Lymphat Res Biol; 2017 Sep; 15(3):262-267. PubMed ID: 28749717
[TBL] [Abstract][Full Text] [Related]
59. Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer.
Sherman KA; Koelmeyer L
Psychooncology; 2013 May; 22(5):1120-6. PubMed ID: 22689156
[TBL] [Abstract][Full Text] [Related]
60. The use of bioimpedance analysis to evaluate lymphedema.
Warren AG; Janz BA; Slavin SA; Borud LJ
Ann Plast Surg; 2007 May; 58(5):541-3. PubMed ID: 17452840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
